The molecular basis of sulfonamide resistance in Toxoplasma gondii and implications for the clinical management of toxoplasmosis

Journal of Infectious Diseases

Volumn 185, Issue 11, 2002, Pages 1637-1643

  Aspinall, Tanya V ^a   Joynson, David H M ^b   Guy, Edward ^b   Hyde, John E ^a   Sims, Paul F G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Toxoplasma Reference Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMETHYLPTERIN; BACTERIAL DNA; DAPSONE; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PTERIN DERIVATIVE; SULFADIAZINE; SULFAFURAZOLE; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFANILAMIDE; SULFONAMIDE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; HUMAN; HUMAN TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; COCCIDIOSTATS; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE; ESCHERICHIA COLI; HUMANS; SEQUENCE ANALYSIS, DNA; SULFONAMIDES; TETRAHYDROFOLATE DEHYDROGENASE; TOXOPLASMA; TOXOPLASMOSIS;

EID: 0036605892     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340577     Document Type: Article

References (26)

1. Biology of Toxoplasma gondii
2. Biology of Toxoplasma gondii
3. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome
4. Toxoplasmic encephalitis in AIDS
5. Treatment of toxoplasmosis in the pregnant mother and newborn child
6. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome
7. Treatment of central nervous system toxoplasmosis with pyrimethamine sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome - Efficacy of long-term continuous therapy
8. Development of sulphonamide resistance in Toxoplasma gondii
9. Toxoplasma gondii: Characterization of a mutant resistant to sulfonamides
10. The dihydrofolate reductase-thymidylate kinase gene in the drug resistance of malaria parasites
11. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization
12. Mutations of dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum
13. Dihydropteroate synthase polymorphisms in Pneumocystis carinii
14. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia
15. Stable molecular transformation of Toxoplasma gondii: A selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria
16. Molecular tools for genetic dissection of the protozoan parasite Toxoplasma gondii
17. Homologous recombination and gene replacement at a dihydrofolate reductase-thymidylate synthase locus in Toxoplasma gondii
18. Primary structure of the dihydrofolate reductase-thymidylate synthase gene from Toxoplasma gondii
19. Isolation and molecular characterization of the bifunctional hydroxymethyldihydropterin pyrophosphokinase-dihydropteroate synthase gene from Toxoplasma gondii
20. Direct PCR from solid tissues without DNA extraction
21. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4
22. Enzymatic reduction of folic acid and dihydrofolic acid to tetrahydrofolic acid
23. 7.8-Dihydropteroate-synthesizing enzyme from Plasmodium chabaudi
24. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria
25. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients
26. Toxoplasma gondii: From animals to humans